Fludarabine, Cyclophosphamide, and Alemtuzumab in Patients With B-cell Chronic Lymphatic Leukemia (B-CLL)

NCT00147901 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

B-cell Chronic Lymphocytic Leukemia

Interventions

DRUG: FCCam

Sponsor

German CLL Study Group

Collaborators

[object Object]
[object Object]